Funabashi, A.; Ito, H.; Maeda, M.; Hasegawa, Y.; Tsukioka, R.; Onda, M.
Evaluation of a Community Pharmacist-Led Intervention Program for Early Detection of Gastrointestinal Adverse Events of Dipeptidyl Peptidase-4 Inhibitors: A Multicenter, Non-Randomized Comparative Study. Pharmacy 2025, 13, 119.
https://doi.org/10.3390/pharmacy13050119
AMA Style
Funabashi A, Ito H, Maeda M, Hasegawa Y, Tsukioka R, Onda M.
Evaluation of a Community Pharmacist-Led Intervention Program for Early Detection of Gastrointestinal Adverse Events of Dipeptidyl Peptidase-4 Inhibitors: A Multicenter, Non-Randomized Comparative Study. Pharmacy. 2025; 13(5):119.
https://doi.org/10.3390/pharmacy13050119
Chicago/Turabian Style
Funabashi, Ayana, Hitoshi Ito, Mamoru Maeda, Yoshitaka Hasegawa, Ryota Tsukioka, and Mitsuko Onda.
2025. "Evaluation of a Community Pharmacist-Led Intervention Program for Early Detection of Gastrointestinal Adverse Events of Dipeptidyl Peptidase-4 Inhibitors: A Multicenter, Non-Randomized Comparative Study" Pharmacy 13, no. 5: 119.
https://doi.org/10.3390/pharmacy13050119
APA Style
Funabashi, A., Ito, H., Maeda, M., Hasegawa, Y., Tsukioka, R., & Onda, M.
(2025). Evaluation of a Community Pharmacist-Led Intervention Program for Early Detection of Gastrointestinal Adverse Events of Dipeptidyl Peptidase-4 Inhibitors: A Multicenter, Non-Randomized Comparative Study. Pharmacy, 13(5), 119.
https://doi.org/10.3390/pharmacy13050119